1. Home
  2. SLS vs RMTI Comparison

SLS vs RMTI Comparison

Compare SLS & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • RMTI
  • Stock Information
  • Founded
  • SLS 2012
  • RMTI 1994
  • Country
  • SLS United States
  • RMTI United States
  • Employees
  • SLS N/A
  • RMTI N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • RMTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLS Health Care
  • RMTI Health Care
  • Exchange
  • SLS Nasdaq
  • RMTI Nasdaq
  • Market Cap
  • SLS 70.1M
  • RMTI 72.7M
  • IPO Year
  • SLS N/A
  • RMTI 1998
  • Fundamental
  • Price
  • SLS $1.06
  • RMTI $2.12
  • Analyst Decision
  • SLS
  • RMTI Strong Buy
  • Analyst Count
  • SLS 0
  • RMTI 2
  • Target Price
  • SLS N/A
  • RMTI $6.00
  • AVG Volume (30 Days)
  • SLS 1.4M
  • RMTI 347.3K
  • Earning Date
  • SLS 11-13-2024
  • RMTI 11-12-2024
  • Dividend Yield
  • SLS N/A
  • RMTI N/A
  • EPS Growth
  • SLS N/A
  • RMTI N/A
  • EPS
  • SLS N/A
  • RMTI N/A
  • Revenue
  • SLS N/A
  • RMTI $98,917,000.00
  • Revenue This Year
  • SLS N/A
  • RMTI $22.58
  • Revenue Next Year
  • SLS N/A
  • RMTI N/A
  • P/E Ratio
  • SLS N/A
  • RMTI N/A
  • Revenue Growth
  • SLS N/A
  • RMTI 22.37
  • 52 Week Low
  • SLS $0.50
  • RMTI $1.16
  • 52 Week High
  • SLS $1.72
  • RMTI $5.15
  • Technical
  • Relative Strength Index (RSI)
  • SLS 55.79
  • RMTI 45.61
  • Support Level
  • SLS $0.87
  • RMTI $1.97
  • Resistance Level
  • SLS $1.01
  • RMTI $2.41
  • Average True Range (ATR)
  • SLS 0.08
  • RMTI 0.11
  • MACD
  • SLS 0.01
  • RMTI 0.02
  • Stochastic Oscillator
  • SLS 73.08
  • RMTI 34.09

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Share on Social Networks: